 | • レポートコード：C-MOR-100272 • 出版社/出版日：Mordor Intelligence / 2019年9月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site License | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、臨床化学分析装置の世界市場について調査・分析し、臨床化学分析装置の世界市場規模、市場動向、市場環境分析、市場展望、セグメント別分析、地域別分析、関連企業情報など以下の構成でお届け致します。 |
Market Overview
The major factors for the growth of the clinical chemistry analyzers market include the rising geriatric population and increasing prevalence of chronic diseases, increasing importance and awareness of point-of-care testing, and rising technological advancements in clinical chemistry analyzer.
The clinical chemistry analyzers run assays on clinical samples such as blood, plasma, urine, and cerebrospinal fluid in order to detect the presence of analytes relating to disease or drugs. The major factor driving the growth of the market includes rising geriatric population and increasing prevalence of chronic diseases. According to the United States Census Bureau’s Statistics, as of 2017, the total number of people aged 65 years and older exceeds 50 million, and between 2020 and 2030, the number of elderly people is projected to increase by almost 18 million. Although much smaller in total size, the number of people aged 85 years and older is expected to more than triple from an estimated 6 million, in the present scenario, to nearly 20 million by 2060. The rising geriatric population will lead to an increase in various diseases resulting in the high demand for clinical tests. Thus, clinical chemistry analyzers are expected to witness high growth over the forecast period.
Scope of the Report
As per the scope of this report, clinical chemistry analyzers run assays on clinical samples such as blood, plasma, urine, and cerebrospinal fluid in order to detect the presence of analytes relating to disease or drugs. The market is segmented by product type, types of test, end-user, and geography.
Key Market Trends
Analyzers Segment is expected to witness the Fastest Growth over the Forecast Period
The analyzers are the instruments which analyze the sample such as blood serum and urine. The clinical chemistry analyzers are witnessing high growth owing to the rising technological advancements in the instruments. The market players are focusing on providing cost-effective equipment to end-user. The automation has become pervasive in clinical laboratories around the world. In order to reduce the healthcare costs, laboratories have relied on automation to maintain profitability as well.
Furthermore, in November 2018 the Primary Health Care has joined forces with Siemens Healthineers to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers. Thus, the rising technological advancements in the analyzers expected to propel the overall growth of the market.
North America is Expected to Dominate the Market
According to the Centers for Disease Control and Prevention, chronic diseases were the leading cause of death and disability in the United States. In addition, rising healthcare expenditure, along with the rapid adoption of point-of-care testing, is expected to boost the growth of the market. The major market players are launching new technologically advanced products in the market. For instance, recently in September 2017, one of the major market player Siemens Healthineers announced the CE Mark and global commercial availability of its Atellica Solution automation-ready immunoassay and chemistry analyzers. Thus, owing to the all above-mentioned factors North America is expected to hold the largest market share.
Competitive Landscape
The market studied is a fragmented market owing to the presence of various market players. Some of the market players are Abbott Laboratories, Danaher Corporation (Beckman Coulter, Inc.), Elitech Group, F.Hoffmann-La Roche Ltd., Horiba, Ltd., Johnson & Johnson, Mindray Medical International Limited, Siemens Healthcare Private Limited, Sysmex Corporation, and Thermo Fisher Scientific Inc.
Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Geriatric Population and Increasing Prevalence of Chronic Diseases
4.2.2 Increasing Importance and Awarenes of Point-of-care testing
4.2.3 Rising Technological Advancements in Clinical Chemistry Analyzer
4.3 Market Restraints
4.3.1 Lack of Trained and Qualified Professionals
4.3.2 High Cost
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Analyzers
5.1.2 Reagents
5.1.3 Others
5.2 By Types of Test
5.2.1 Liver Panels
5.2.2 Electrolyte Panels
5.2.3 Thyroid Function Panels
5.2.4 Lipid Profiles
5.2.5 Others
5.3 By End User
5.3.1 Hospital
5.3.2 Diagnostic Laboratories
5.3.3 Academic Institutes
5.3.4 Others
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Danaher Corporation (Beckman Coulter, Inc.)
6.1.3 Elitech Group
6.1.4 F.Hoffmann-La Roche Ltd.
6.1.5 Horiba, Ltd.
6.1.6 Johnson & Johnson
6.1.7 Mindray Medical International Limited
6.1.8 Siemens Healthcare Private Limited
6.1.9 Sysmex Corporation
6.1.10 Thermo Fisher Scientific Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS